Biotech Co. Investors Clash Over 'Self-Dealing' Claim
law360
2 months ago
81 views
Attorneys for a biopharmaceutical and technology company stockholder and a group of venture investors sharply disagreed Tuesday over whether a financing deal was a lifeline for a struggling company or a self-serving maneuver that enriched insiders, as they argued a motion to dismiss the derivative suit in the Delaware Chancery Court.
Continue Reading
Sign up for FREE to read the full article and access 131K+ alternative investment headlines.